Overview
Availability
- Dr Paul Clark is:
- Available for supervision
Qualifications
- Bachelor (Honours) of Medicine Surgery, The University of Queensland
- Masters (Coursework) of Public Health and Tropical Medicine, James Cook University
- Doctor of Philosophy, University of New South Wales
- Royal Australasian College of Physicians, Royal Australasian College of Physicians
Works
Search Professor Paul Clark’s works on UQ eSpace
2014
Conference Publication
Genetic variation in PNPLA3 (rs738409) and risk of esophageal adenocarcinoma
Choo, A. C., Thrift, A. P., Whiteman, D. C. and Clark, P. J. (2014). Genetic variation in PNPLA3 (rs738409) and risk of esophageal adenocarcinoma. HOBOKEN: WILEY-BLACKWELL.
2014
Journal Article
Trends in hepatitis C treatment uptake in the United States
Clark, Paul J., Thompson, Alexander J., Patel, Keyur, Muir, Andrew J. and Volk, Michael L. (2014). Trends in hepatitis C treatment uptake in the United States. Hepatology, 60 (2), 768-769. doi: 10.1002/hep.27213
2014
Journal Article
Osteopontin is up-regulated in chronic hepatitis C and is associated with cellular permissiveness for hepatitis C virus replication
Choi, Steve S., Claridge, Lee C., Jhaveri, Ravi, Swiderska-Syn, Marzena, Clark, Paul, Suzuki, Ayako, Pereira, Thiago A., Mi, Zhiyong, Kuo, Paul C., Guy, Cynthia D., Pereira, Fausto E. L., Diehl, Anna Mae, Patel, Keyur and Syn, Wing-Kin (2014). Osteopontin is up-regulated in chronic hepatitis C and is associated with cellular permissiveness for hepatitis C virus replication. Clinical Science, 126 (12), 845-855. doi: 10.1042/CS20130473
2014
Journal Article
The association of Il28b genotype with the histological features of chronic hepatitis C Is HCV genotype dependent
D'Ambrosio, R., Aghemo, A., De Francesco, R., Rumi, M. G., Galmozzi, E., De Nicola, S., Cheroni, C., Clark, P. J., Ronchi, G., Lampertico, P. and Colombo, M. (2014). The association of Il28b genotype with the histological features of chronic hepatitis C Is HCV genotype dependent. International Journal of Molecular Sciences, 15 (5), 7213-7224. doi: 10.3390/ijms15057213
2014
Journal Article
Enhancing hepatitis C treatment in the custodial setting: a national roadmap. Challenges and opportunities for enhanced services
Mina, Michael M., Clark, Paul J., Beasley, Holly M., Herawati, Lilie, Butler, Tony G. and Lloyd, Andrew R. (2014). Enhancing hepatitis C treatment in the custodial setting: a national roadmap. Challenges and opportunities for enhanced services. Medical Journal of Australia, 200 (1), 15-16. doi: 10.5694/mja13.10654
2014
Journal Article
Recurrence of hepatocellular carcinoma: Importance of mRECIST response to chemoembolization and tumor size
Kim, D. J., Clark, P. J., Heimbach, J., Rosen, C., Sanchez, W., Watt, K. and Charlton, M. R. (2014). Recurrence of hepatocellular carcinoma: Importance of mRECIST response to chemoembolization and tumor size. American Journal of Transplantation, 14 (6), 1383-1390. doi: 10.1111/ajt.12684
2014
Book Chapter
Hepatitis C Virus
Thompson, A. J., Clark, P. and Aghemo, A. (2014). Hepatitis C Virus. Handbook of Pharmacogenomics and Stratified Medicine. (pp. 859-877) edited by Sandosh Padmanabhan . London, UK: Academic Press. doi: 10.1016/B978-0-12-386882-4.00037-2
2013
Journal Article
Predictors of consent to pharmacogenomics testing in the IDEAL study
Jazwinski, Alison B., Clark, Paul J., Thompson, Alexander J., Gordon, Stuart C., Lawitz, Eric J., Noviello, Stephanie, Brass, Clifford A., Pedicone, Lisa D., Albrecht, Janice K., Sulkowski, Mark S. and Muir, Andrew J. (2013). Predictors of consent to pharmacogenomics testing in the IDEAL study. Pharmacogenetics and Genomics, 23 (11), 619-623. doi: 10.1097/FPC.0000000000000002
2013
Conference Publication
ITPA genotype predicts the development of on-treatment anaemia after 4 weeks of protease inhibitor therapy irrespective of fibrosis stage and past treatment experience status: A multi-centre real-life experience
Holmes, J. A., Mangia, A., Clark, P. J., Iser, D. M., Nguyen, T., Bell, S. J., Ryan, M., Bonanzinga, S., Desmond, P. V., Petruzzellis, D., Bowden, D. S. and Thompson, A. J. (2013). ITPA genotype predicts the development of on-treatment anaemia after 4 weeks of protease inhibitor therapy irrespective of fibrosis stage and past treatment experience status: A multi-centre real-life experience. HOBOKEN: WILEY-BLACKWELL.
2013
Conference Publication
ITPA ACTIVITY PREDICTS Hb DECLINE AFTER FOUR WEEKS OF PI TRIPLE THERAPY, REGARDLESS OF PREVIOUS TREATMENT OR NAIVE STATUS AND FIBROSIS: A MULTICENTER REAL-LIFE EXPERIENCE
Mangia, A., Clark, P. J., Piazzolla, V., Santoro, R., Holmes, J. A., Mottola, L., Ripoli, M., Iser, D., Nguyen, T., Bell, S. J., Desmond, P. V., Petruzzellis, D., Patel, K., Muir, A. J. and Thompson, A. J. (2013). ITPA ACTIVITY PREDICTS Hb DECLINE AFTER FOUR WEEKS OF PI TRIPLE THERAPY, REGARDLESS OF PREVIOUS TREATMENT OR NAIVE STATUS AND FIBROSIS: A MULTICENTER REAL-LIFE EXPERIENCE. International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Amsterdam Netherlands, Apr 24-28, 2013. AMSTERDAM: ELSEVIER SCIENCE BV.
2013
Journal Article
Inosine triphosphatase deficiency helps predict anaemia, anaemia management and response in chronic hepatitis C therapy
Clark, P. J., Aghemo, A., Degasperi, E., Galmozzi, E., Urban, T. J., Vock, D. M., Patel, K., Thompson, A. J., Rumi, M. G., D'Ambrosio, R., Muir, A. J. and Colombo, M. (2013). Inosine triphosphatase deficiency helps predict anaemia, anaemia management and response in chronic hepatitis C therapy. Journal of Viral Hepatitis, 20 (12), 858-866. doi: 10.1111/jvh.12113
2012
Journal Article
Search for anomalous production of prompt like-sign lepton pairs at √<i>s</i>=7 TeV with the ATLAS detector
Aad, G., Abajyan, T., Abbott, B., Abdallah, J., Khalek, S. Abdel, Abdelalim, A. A., Abdinov, O., Aben, R., Abi, B., Abolins, M., AbouZeid, O. S., Abramowicz, H., Abreu, H., Acerbi, E., Acharya, B. S., Adamczyk, L., Adams, D. L., Addy, T. N., Adelman, J., Adomeit, S., Adragna, P., Adye, T., Aefsky, S., Aguilar-Saavedra, J. A., Agustoni, M., Aharrouche, M., Ahlen, S. P., Ahles, F., Ahmad, A. ... Zwalinski, L. (2012). Search for anomalous production of prompt like-sign lepton pairs at √s=7 TeV with the ATLAS detector. Journal of High Energy Physics, 2012 (12) 007. doi: 10.1007/JHEP12(2012)007
2012
Journal Article
Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: Impaired viral kinetics and therapeutic response
Naggie, Susanna, Osinusi, Anu, Katsounas, Antonios, Lempicki, Richard, Herrmann, Eva, Thompson, Alexander J., Clark, Paul J., Patel, Keyur, Muir, Andrew J., McHutchison, John G., Schlaak, Joerg F., Trippler, Martin, Shivakumar, Bhavana, Masur, Henry, Polis, Michael A. and Kottilil, Shyam (2012). Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: Impaired viral kinetics and therapeutic response. Hepatology, 56 (2), 444-454. doi: 10.1002/hep.25647
2012
Journal Article
The Association of Genetic Variants with Hepatic Steatosis in Patients with Genotype 1 Chronic Hepatitis C Infection (vol 57, pg 2213, 2012)
Clark, Paul J., Thompson, Alexander J., Zhu, Qianqian, Vock, David M., Zhu, Mingfu, Patel, Keyur, Harrison, Stephen A., Naggie, Susanna, Ge, Dongliang, Tillmann, Hans L., Urban, Thomas J., Shianna, Kevin, Fellay, Jacques, Goodman, Zachary, Noviello, Stephanie, Pedicone, Lisa D., Afdhal, Nezam, Sulkowski, Mark, Albrecht, Janice K., Goldstein, David B., McHutchison, John G. and Muir, Andrew J. (2012). The Association of Genetic Variants with Hepatic Steatosis in Patients with Genotype 1 Chronic Hepatitis C Infection (vol 57, pg 2213, 2012). Digestive Diseases and Sciences, 57 (9), 2479-2479. doi: 10.1007/s10620-012-2309-y
2012
Journal Article
Overcoming Barriers to Care for Hepatitis C
Clark, Paul J. and Muir, Andrew J. (2012). Overcoming Barriers to Care for Hepatitis C. New England Journal of Medicine, 366 (26), 2436-2438. doi: 10.1056/NEJMp1202608
2012
Journal Article
Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response
Clark, P. J., Thompson, A. J., Zhu, M., Vock, D. M., Zhu, Q., Ge, D., Patel, K., Harrison, S. A., Urban, T. J., Naggie, S., Fellay, J., Tillmann, H. L., Shianna, K., Noviello, S., Pedicone, L. D., Esteban, R., Kwo, P., Sulkowski, M. S., Afdhal, N., Albrecht, J. K., Goldstein, D. B., McHutchison, J. G. and Muir, A. J. (2012). Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response. Journal of Viral Hepatitis, 19 (5), 332-340. doi: 10.1111/j.1365-2893.2011.01553.x
2012
Conference Publication
Association of Serum Adipocytokines With IL28B and SVR in Chronic Hepatitis C
Clark, Paul J., Thompson, Alexander J., Jazwinski, Alison, Tillmann, Hans L., Naggie, Susanna, Muir, Andrew J. and Patel, Keyur (2012). Association of Serum Adipocytokines With IL28B and SVR in Chronic Hepatitis C. Digestive Disease Week (DDW), San Diego Ca, May 19-22, 2012. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC.
2012
Journal Article
Elevated serum CK18 levels in chronic hepatitis C patients are associated with advanced fibrosis but not steatosis
Jazwinski, A. B., Thompson, A. J., Clark, P. J., Naggie, S., Tillmann, H. L. and Patel, K. (2012). Elevated serum CK18 levels in chronic hepatitis C patients are associated with advanced fibrosis but not steatosis. Journal of Viral Hepatitis, 19 (4), 278-282. doi: 10.1111/j.1365-2893.2011.01546.x
2012
Journal Article
Reply to "IL28B polymorphism and hepatitis C: A genetic marker of peginterferon-alpha sensitivity devoid from classical interferon-alpha side effects?"
Thompson, A. J., Clark, P. J., Muir, A. J. and Sulkowski, M. S. (2012). Reply to "IL28B polymorphism and hepatitis C: A genetic marker of peginterferon-alpha sensitivity devoid from classical interferon-alpha side effects?". Journal of Hepatology, 56 (3), 742-743. doi: 10.1016/j.jhep.2011.08.011
2012
Journal Article
Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients
Thompson, Alexander J., Clark, Paul J., Singh, Abanish, Ge, Dongliang, Fellay, Jacques, Zhu, Mingfu, Zhu, Qianqian, Urban, Thomas J., Patel, Keyur, Tillmann, Hans L., Naggie, Susanna, Afdhal, Nezam H., Jacobson, Ira M., Esteban, Rafael, Poordad, Fred, Lawitz, Eric J., McCone, Jonathan, Shiffman, Mitchell L., Galler, Greg W., King, John W., Kwo, Paul Y., Shianna, Kevin V., Noviello, Stephanie, Pedicone, Lisa D., Brass, Clifford A., Albrecht, Janice K., Sulkowski, Mark S., Goldstein, David B., McHutchison, John G. and Muir, Andrew J. (2012). Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients. Journal of Hepatology, 56 (2), 313-319. doi: 10.1016/j.jhep.2011.04.021
Funding
Current funding
Supervision
Availability
- Dr Paul Clark is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Available projects
-
Approaches to evaluating fibrosis and treating viral hepatitis remotely in regional Queensland
Supervision history
Current supervision
-
Doctor Philosophy
The role of the gut microbiome in alcohol related liver disease
Principal Advisor
Other advisors: Professor Jason Connor, Professor Gerald Holtmann
Completed supervision
-
2022
Doctor Philosophy
Epidemiology of viral hepatitis and liver diseases in migrant communities in Australia
Principal Advisor
Media
Enquiries
For media enquiries about Dr Paul Clark's areas of expertise, story ideas and help finding experts, contact our Media team: